Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Measuring time to fusion as a means of determining degree of parallel activation of the heart

a technology of parallel activation and measuring time, which is applied in the direction of angiography, therapy, artificial respiration, etc., can solve the problems of not all patients benefiting from such therapy, patients may experience deterioration, and morbidity

Pending Publication Date: 2022-07-28
PACERTOOL AS
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent is about analyzing electrical activation in the heart to determine the degree of parallel activation, which is important for understanding heart rhythms. The patent explains that a delay in the time it takes for the tissue to fuse indicates that more tissue is being activated before the wave fronts meet. The patent also mentions using different reference points in the data to compare different measurements. The compensation for time delays between the reference points allows for more accurate comparisons. This technology helps to better understand and diagnose heart rhythm abnormalities.

Problems solved by technology

CRT is associated with a reduction in mortality and morbidity, however, not all patients benefit from such therapy.
In fact, some patients may experience deterioration after treatment, some experience devastating complications, and some experience both.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Measuring time to fusion as a means of determining degree of parallel activation of the heart
  • Measuring time to fusion as a means of determining degree of parallel activation of the heart
  • Measuring time to fusion as a means of determining degree of parallel activation of the heart

Examples

Experimental program
Comparison scheme
Effect test

example method

[0359]The systems and methods described herein may be used both before and during treatment of patients with presumably dyssynchronous heart failure, with a resynchronization pacemaker (CRT) in order 1) identify the presence of an underlying substrate that identifies patients that are likely to respond positively (manifest resynchronization potential present) to and 2) identify optimal locations for placement of pacing leads / electrodes.

[0360]Patients are currently referred for implantation of a CRT pacemaker based on international guidelines that describe indication criteria. These criteria are based on inclusion criteria in larger clinical trials and, amongst other things, consists of symptoms of heart failure, reduced ejection fraction (heart function) and a widened QRS complex (preferably left bundle branch block) beyond 120-150 ms. However, currently only 50-70% of patients with one or more indications for treatment with a CRT actually respond to treatment. Reasons for these non...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method for determining the degree of parallel activation of a heart undergoing pacing includes calculating vectorcardiogram (VCG), or electrocardiogram (ECG), or electrogram (EGM) waveforms from right ventricular pacing (RVp) and left ventricular pacing (LVp). A synthetic biventricular pacing (BIVP) waveform is generated by summing the VCG of the RVp and LVp, or by summing the ECG of the RVp and the LVp, or by summing the EGM of the RVp and the LVp. A corresponding EGM or ECG or VCG waveform from real BIVP is calculated. The method includes comparing the synthetic BIVP waveform and the real BIVP waveform and calculating time to fusion by determining the point in time in which the activation from RVp and LVp meets and the synthetic and the real BIVP curves start to deviate. A delay in time to fusion indicates a higher degree of parallel activation.

Description

TECHNICAL FIELD[0001]The present invention is concerned with a method and system for measuring time to fusion as a means of determining degree of parallel activation of the heart. Thus, the invention may be used in relation to patients undergoing pacing, and more specifically can apply to the identification of the degree of parallel activation of a paced heart. A delay in time to fusion indicates that a larger amount of tissue is activated before wave fronts for electrical activation meet, thereby indicating a higher degree of parallel activation, and to what extent the pacing of a heart results in effective resynchronisation.BACKGROUND OF THE INVENTION[0002]Cardiac resynchronization therapy (CRT) is consistently provided according to recognized medical standards and guidelines provided by international medical societies in order to treat patients suffering from various conditions such as a widened QRS complex, (left or right) bundle branch block and heart failure. There are some mi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61B5/0215A61N1/368A61B5/0538A61B5/055A61B5/327A61B5/341A61B5/343A61B5/349A61B5/367A61B5/00A61N1/36A61N1/362
CPCA61B5/0215A61B2034/105A61N1/36842A61B5/0538A61B5/055A61B5/327A61B5/341A61B5/343A61B5/349A61B5/367A61B5/7425A61N1/36128A61N1/3622A61N1/3627A61N1/36843A61N1/3686A61N1/36507A61B2562/0219A61B5/316
Inventor ODLAND, HANS HENRIK
Owner PACERTOOL AS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com